Bromantane
weak data
The Dose Guy’s verdictSep 1, 20263 sources
Bromantane is the most interesting actoprotector on this shelf, a genuine dopamine-synthesis upregulator with Russian clinical approval and a WADA ban that together confirm it does something real. The catch: the human data is two small Russian studies, one from 1993 and one from 2000, and everything else is animal work or community reports. I’d run it for low-key energy and drive before I’d run most research chemicals here, but I’d want you to know the evidence base is thin and the long-term picture is short.
What it is
Bromantane is not a stimulant in the usual sense. Where amphetamines or modafinil block reuptake or force release, bromantane nudges the enzymes that build dopamine and serotonin, upregulating tyrosine hydroxylase and aromatic L-amino acid decarboxylase so your neurons make more transmitter at the factory level. The result is a slow, smooth lift in motivation and stress tolerance without the jitter, crash, or tolerance spiral of a classical stimulant. It also carries a mild anxiolytic component, which is part of why the experience feels clean rather than wired.
Russia approved it for asthenia, the medical term for chronic fatigue and low drive, Athletes tested positive for it at the 1996 Olympics, and WADA has listed it as prohibited since, which tells you two things at once: it has real effects, and the human safety data still rests almost entirely on Russian clinical use rather than Western trials. On the nootropic shelf it sits next to chlodantane, a near-relative with even less behind it.
What the research shows
Two small Russian studies from 1993 and 2000, a stack of animal work from the same era, and nothing modern:
Realistic protocols
The community runs bromantane for a steady baseline lift in energy, drive, and stress tolerance, not for an acute kick. Start at 50 mg once in the morning, oral. Most people settle between 50 and 100 mg daily, and the effect builds over days rather than hitting all at once, which matches a synthesis-upregulation mechanism rather than a reuptake block. Some run it sublingual for faster onset, though the taste is rough. Going above 100 mg rarely adds much and starts pulling side effects. Unlike classical stimulants, tolerance buildup is not a major community complaint, and cycles are less strict, but reassessing every couple of months is still sensible because the long-term human data does not exist.
Morning dosing matters. Bromantane has a long enough action that afternoon or evening doses can push into sleep. It plays well with most nootropic stacks, but avoid layering it with other dopaminergic compounds unless you know what you are doing, because the synthesis-boosting mechanism can compound. Caffeine pairs well, most people run both without issues. Alcohol has no documented interaction, but the clean baseline bromantane builds makes the next-day contrast rougher.
Side effects
Mild profile for most people, consistent with a synthesis modulator rather than a stimulant:
